KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biogen (BIIB) Restructuring Costs (2016 - 2025)

Biogen has reported Restructuring Costs over the past 12 years, most recently at $6.6 million for Q4 2025.

  • Quarterly results put Restructuring Costs at $6.6 million for Q4 2025, up 24.53% from a year ago — trailing twelve months through Dec 2025 was $48.6 million (up 60.93% YoY), and the annual figure for FY2025 was $48.6 million, up 60.93%.
  • Restructuring Costs for Q4 2025 was $6.6 million at Biogen, down from $7.4 million in the prior quarter.
  • Over the last five years, Restructuring Costs for BIIB hit a ceiling of $900.0 million in Q2 2022 and a floor of -$700000.0 in Q2 2025.
  • Median Restructuring Costs over the past 4 years was $7.2 million (2022), compared with a mean of $72.2 million.
  • Biggest five-year swings in Restructuring Costs: surged 1311.43% in 2023 and later crashed 110.61% in 2025.
  • Biogen's Restructuring Costs stood at $7.0 million in 2022, then surged by 1311.43% to $98.8 million in 2023, then plummeted by 94.64% to $5.3 million in 2024, then increased by 24.53% to $6.6 million in 2025.
  • The last three reported values for Restructuring Costs were $6.6 million (Q4 2025), $7.4 million (Q3 2025), and -$700000.0 (Q2 2025) per Business Quant data.